跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,202 条关于
“Lobe Sciences”
全部
5,202
临床试验
739
药物
573
机构
591
资讯
3,299
去年
Lobe Sciences Secures European Patent Protection for DHA-Based Sickle Cell Disease Treatment
去年
Lobe Sciences Secures $6M Private Placement for Novel Conjugated Psilocin Development in Chronic Cluster Headache
4个月前
Lobe Sciences Advances L-130 for Chronic Cluster Headache and S-100 for Sickle Cell Disease, Targets Late 2026 IND Filing
4天前
Lobe Sciences to Present Phase 1a Low-Dose Psilocin Data for L-130 at Neuropsychiatric Drug Development Summit
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
Gilead Defends TDF Development Amidst Litigation, Cites Patient Needs and FDA Guidance
去年
uniQure's Gene Therapy AMT-260 Achieves 92% Seizure Reduction in First Drug-Resistant Epilepsy Patient
8个月前
Prudentia Sciences Raises $20M Series A to Transform Life Sciences Due Diligence with AI Platform
去年
BIOQuébec and Life Sciences British Columbia Form Strategic Alliance to Strengthen Canada's Life Sciences Ecosystem
第 1 页,共 330 页
上一页
下一页